$PRVCF will be hosting an update for the investment community, media, and shareholders on the status of PreveCeutical's business and its future plans and projects. The presentations will be regarding PreveCeutical's intent to acquire the Penta 5 Group, a progress update on the research programs, the newly launched Cannabis Division and business partnership with Asterion Cannabis, Inc. Seating is on a first come first serve basis. Tuesday, 16 October 2018 from 1:00-2:00pm https://www.eventbrite.ca/e/preveceutical-med...rm=listing